Suppr超能文献

CD74 作为正常 B 细胞中转录的调节因子。

CD74 as a regulator of transcription in normal B cells.

机构信息

Department of Systems Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.

The Mantoux Bioinformatics Institute of the Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot 76100, Israel.

出版信息

Cell Rep. 2022 Nov 1;41(5):111572. doi: 10.1016/j.celrep.2022.111572.

Abstract

CD74 is receptor for the cytokine macrophage migration inhibitory factor (MIF). MIF binding to CD74 induces a signaling cascade resulting in the release of its cytosolic intracellular domain (CD74-ICD) that serves as a transcriptional regulator in chronic lymphocytic leukemia (CLL) cells. In the current study, we investigated the transcriptional and regulatory function of CD74-ICD in normal B cells. We show that following activation, CD74-ICD forms a complex in the cytosol with transcription factors, like PAX5, and binds the chromatin at a significantly higher number of sites compared with its binding in CLL cells. The expression of a major portion of these bound genes is shut down in the malignant cells. The CD74-ICD:PAX5 complex binds the promoter areas of a tumor-suppressor gene, DMTF1, and downregulates its expression through inhibition of transcription. These findings can help identify novel therapeutic pathways that are regulated during oncogenic transformation and are targets for future treatments.

摘要

CD74 是细胞因子巨噬细胞移动抑制因子(MIF)的受体。MIF 与 CD74 结合诱导信号级联反应,导致其胞质细胞内结构域(CD74-ICD)释放,CD74-ICD 作为慢性淋巴细胞白血病(CLL)细胞中的转录调节剂。在本研究中,我们研究了 CD74-ICD 在正常 B 细胞中的转录和调节功能。我们发现,在激活后,CD74-ICD 在细胞质中与转录因子(如 PAX5)形成复合物,并与染色质结合的位点数量明显高于 CLL 细胞中的结合位点。这些结合基因的大部分表达在恶性细胞中被关闭。CD74-ICD:PAX5 复合物结合肿瘤抑制基因 DMTF1 的启动区,并通过抑制转录来下调其表达。这些发现可以帮助确定在致癌转化过程中受到调控的新的治疗途径,是未来治疗的靶点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验